- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06176001
Group-based Psychoeducation for Relatives of Patients With Bipolar Disorder, a Randomized Controlled Trial (R-Bipolar)
Group-based Psychoeducation for Relatives of Patients With Bipolar Disorder - a Large Scale Real-world Randomized Controlled Parallel Group Trial
Relatives of patients with bipolar disorder (BD) often experience emotional burden with stress, and depressive symptoms that again increases the likelihood of destabilization and relapses in the patient. The effects of group-based psychoeducation have not been investigated in large-scale real-world settings. The investigators are currently conducting a large-scale real-world randomized controlled parallel group trial (RCT) to test whether group-based psychoeducation for relatives to patients with BD improves mood instability and other critical outcomes in relatives and the corresponding patients with BD.
The trial is designed as a two-arm, parallel group randomized trial with a balanced randomization 1:1 to either group-based psychoeducation or a waiting list for approximately 4 months and subsequent group-based psychoeducation. the investigators plan to include 200 relatives. The group sizes for psychoeducation is between 20-40 relatives.The primary outcome measure is mood instability calculated based on daily smartphone-based mood self-assessment. Other relevant outcomes are measured, including patients' reported outcomes, assessing self-assessed burden, self-efficacy, and knowledge about BD.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Lars V Kessing, professor
- Phone Number: +4538647081
- Email: lars.vedel.kessing@regionh.dk
Study Contact Backup
- Name: Julie R Stokholm, MD
- Phone Number: +4540158739
- Email: julie.ravneberg.stokholm@regionh.dk
Study Locations
-
-
-
Copenhagen, Denmark, 2000
- Recruiting
- Copenhagen Affective Disorder Clinic
-
Contact:
- Lars V Kessing, professor
- Phone Number: 38647081
- Email: lars.vedel.kessing@regionh.dk
-
Contact:
- Julie R Stokholm, MD
- Phone Number: 40158739
- Email: julie.ravneberg.stokholm@regionh.dk
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Relatives of patients with Bipolar Disorder who are affiliated with the Copenhagen Affective Disorder Clinic.
Exclusion Criteria:
- Insufficient Danish language.
- Age below 18 years.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Psychoeducation
Participants randomized to this arm are offered group-based psychoeducation shortly thereafter.
|
Group-based psychoeducation for relatives.
Group size: 20-40 relatives.
Duration of intervention: six sessions, each two hours long with a 15 minutes break, over a period of 6-10 weeks.
The sessions are held by experienced clinicians from the Copenhagen Affective Disorder Clinic, one chief physician and one nurse.
Each session focuses on a specific topic, which the clinicians present and discuss using a presentation viewer.
The sessions are interactive, and the participants are encouraged to ask questions during the presentations.
During each session the participants will have some discussions in smaller groups to reflect on a topics and issues raised during the session.
|
Placebo Comparator: Waiting list
Participants randomized to this arm are placed on a waiting list for approximately 4 months and then offered group-based psychoeducation thereafter.
|
Group-based psychoeducation for relatives.
Group size: 20-40 relatives.
Duration of intervention: six sessions, each two hours long with a 15 minutes break, over a period of 6-10 weeks.
The sessions are held by experienced clinicians from the Copenhagen Affective Disorder Clinic, one chief physician and one nurse.
Each session focuses on a specific topic, which the clinicians present and discuss using a presentation viewer.
The sessions are interactive, and the participants are encouraged to ask questions during the presentations.
During each session the participants will have some discussions in smaller groups to reflect on a topics and issues raised during the session.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in mood instability in the relatives
Time Frame: daily in 4-8 months.
|
Mood instability is calculated from daily self-reported mood registration in the app Monsenso. Participating relatives score their daily mood on a 9-point scale from 0-8 where 8 is 'in a brilliant mood' and 0 is 'really sad' The participant rate daily in the Monsenso app during the time the participate in the study (4-8 months depending on which group they are randomly allocated to). For each participant, a mood instability measure will be estimated for each day and aggregated by applying the root mean square successive difference (rMSSD) method. |
daily in 4-8 months.
|
Change in mood instability in the corresponding patients
Time Frame: daily in 4-8 months.
|
Mood instability is calculated from daily self-reported mood registration via the app Monsenso.
The patients score their daily mood on a scale from -3 to +3, where -3 is the worst and +3 is the best mood.
Patients' data from the Monsenso app is collected from a parallel RCT, in the time frame in which the relatives are in the study.
|
daily in 4-8 months.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Self-reported daily registrations in the Monsenso app on the following topics: daily activity level, sleep, mixed moods, anxiety, irritability, cognition, stress, alchohol consumption, patient support and level of burden from being a caregiver,
Time Frame: daily 4-8 months.
|
Each topic is covered by a single, simple question in the Monsenso app:
|
daily 4-8 months.
|
Self-rated caregiver burden
Time Frame: at inclusion, at follow-up around 4 months, and if in control group at around 7-8 months
|
Burden Assessment Scale 19 questions covering subjects as economic and practical burden, stigma, worries, conflicts etc, participants answer on a scale from [1: not at all] to [4: to a high degree] or [not relevant] Reinhard SC, Gubman GD, Horwitz AV, Minsky S. Burden assessment scale for families of the seriously mentally ill. Eval Program Plann. 1. juli 1994;17(3):261-9. |
at inclusion, at follow-up around 4 months, and if in control group at around 7-8 months
|
Self-rated expressed emotions
Time Frame: at inclusion, at follow-up around 4 months, and if in control group at around 7-8 months
|
Perceived Criticism Measure The questionnaire consists of four questions covering criticism in a relationship, answered on a scale from 0 to 10, where 10 is the highest and most negative. Hooley JM, Parker HA. Measuring expressed emotion: An evaluation of the shortcuts. J Fam Psychol. september 2006;20(3):386-96. |
at inclusion, at follow-up around 4 months, and if in control group at around 7-8 months
|
Self-rated quality of life
Time Frame: at inclusion, at follow-up around 4 months, and if in control group at around 7-8 months
|
Carer Quality of Life 7 multiple-answer questions and one Visual Analog Scale to evaluate quality of life in the light of being an informal caregiver. Brouwer WBF, van Exel NJA, van Gorp B, Redekop WK. The CarerQol instrument: A new instrument to measure care-related quality of life of informal caregivers for use in economic evaluations. Qual Life Res. 1. august 2006;15(6):1005-21. Hoefman RJ, van Exel NJA, Looren de Jong S, Redekop WK, Brouwer WBF. A new test of the construct validity of the CarerQol instrument: measuring the impact of informal care giving. Qual Life Res. 2011;20(6):875-87. |
at inclusion, at follow-up around 4 months, and if in control group at around 7-8 months
|
Self-rated carer self-efficacy
Time Frame: at inclusion, at follow-up around 4 months, and if in control group at around 7-8 months
|
Carer-Self-Efficacy 12 questions about self-efficacy as a caregiver for a person with Bipolar disorder. The questionnaire was originally developed for persons with bipolar disorder (Smith) and later Hubbard et al made a version for caregivers. Smith LM, Erceg-Hurn DM, McEvoy PM, Lim L. Self-efficacy in bipolar disorder: Development and validation of a self-report scale. J Affect Disord. 1. februar 2020;262:108-17. Hubbard AA, McEvoy PM, Smith L, Kane RT. Brief group psychoeducation for caregivers of individuals with bipolar disorder: A randomized controlled trial. J Affect Disord. august 2016;200:31-6. |
at inclusion, at follow-up around 4 months, and if in control group at around 7-8 months
|
Knowledge about bipolar
Time Frame: at inclusion, at follow-up around 4 months, and if in control group at around 7-8 months
|
25 questions testing the factual knowledge about bipolar disorder. "The Bipolar disorders knowledge scale", Trevor A. Stump and Marty L. Eng. Journal of Affective disorders, 2018-10-01, Volume 238, Pages 645-650. |
at inclusion, at follow-up around 4 months, and if in control group at around 7-8 months
|
Self-rated health related quality of life
Time Frame: at inclusion, at follow-up around 4 months, and if in control group at around 7-8 months
|
Short Form-12 (54,55) 12 questions on health-related quality of life. Christensen LN, Ehlers L, Larsen FB, Jensen MB. Validation of the 12 Item Short form Health Survey in a Sample from Region Central Jutland. Soc Indic Res. 1. november 2013;114(2):513-21. Amir M, Lewin-Epstein N, Becker G, Buskila D. Psychometric properties of the SF-12 (Hebrew version) in a primary care population in Israel. Med Care. oktober 2002;40(10):918-28. |
at inclusion, at follow-up around 4 months, and if in control group at around 7-8 months
|
Self-rated mental health
Time Frame: at inclusion, at follow-up around 4 months, and if in control group at around 7-8 months
|
The Brief Symptom Inventory (BSI: Derogatis, 1992), a 53-item self-report inventory of psychopathology and psychological distress, the BSI psychometric profile produces the same nine primary symptom dimensions produced by the SCL-90-R. Derogatis LR, Melisaratos N. The Brief Symptom Inventory: an introductory report. Psychol Med. august 1983;13(3):595-605. |
at inclusion, at follow-up around 4 months, and if in control group at around 7-8 months
|
Self-rated stress
Time Frame: at inclusion, at follow-up around 4 months, and if in control group at around 7-8 months
|
Perceived Stress Scale 10 questions covering stress symptoms in the last month. Cohen S. Perceived stress in a probability sample of the United States. I: The social psychology of health. Thousand Oaks, CA, US: Sage Publications, Inc; 1988. s. 31-67. (The Claremont Symposium on Applied Social Psychology). |
at inclusion, at follow-up around 4 months, and if in control group at around 7-8 months
|
Self-rated bipolar symptoms
Time Frame: at inclusion, at follow-up around 4 months, and if in control group at around 7-8 months
|
Mood Disorder Questionnaire Hirschfeld RMA, Williams JBW, Spitzer RL, Calabrese JR, Flynn L, Keck PE, m.fl. Development and Validation of a Screening Instrument for Bipolar Spectrum Disorder: The Mood Disorder Questionnaire. Am J Psychiatry. november 2000;157(11):1873-5. |
at inclusion, at follow-up around 4 months, and if in control group at around 7-8 months
|
Self-rated depressive symptoms
Time Frame: at inclusion, at follow-up around 4 months, and if in control group at around 7-8 months
|
Major Depression Inventory Bech P, Timmerby N, Martiny K, Lunde M, Soendergaard S. Psychometric evaluation of the Major Depression Inventory (MDI) as depression severity scale using the LEAD (Longitudinal Expert Assessment of All Data) as index of validity. BMC Psychiatry. 5. august 2015;15:190. Bech P, Wermuth L. Applicability and validity of the Major Depression Inventory in patients with Parkinson's disease. Nord J Psychiatry. (52):305-10. |
at inclusion, at follow-up around 4 months, and if in control group at around 7-8 months
|
Self-rated Childhood trauma
Time Frame: Only at inclusion
|
Childhood Trauma Questionnaire (CTQ) Bernstein DP, Fink L, Handelsman L, Foote J, Lovejoy M, Wenzel K, m.fl. Initial reliability and validity of a new retrospective measure of child abuse and neglect. Am J Psychiatry. august 1994;151(8):1132-6. |
Only at inclusion
|
Clinically observer rated Depressive symptoms
Time Frame: At inclusion, at 3-4 months and for the control-group also at 7-8 months.
|
Depressive symptoms assessed by the Hamilton Depression Rating Scale-6 items (min. value = 0; max. value = 22, with higher values reflecting more depressive symptoms) Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. februar 1960;23(1):56-62. |
At inclusion, at 3-4 months and for the control-group also at 7-8 months.
|
Clinically observer rated Manic symptoms
Time Frame: at inclusion, at follow-up around 4 months, and if in control group at around 7-8 months
|
Manic symptoms assessed by the Young Mania Rating Scale (min. value = 0; max. value = 60, with higher values reflecting more manic symptoms) Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry J Ment Sci. november 1978;133:429-35. |
at inclusion, at follow-up around 4 months, and if in control group at around 7-8 months
|
Clinically observer rated General functioning
Time Frame: at inclusion, at follow-up around 4 months, and if in control group at around 7-8 months
|
General functioning assessed by the Functional Assessment Short Test, a 24-item interviewer-administered interview concerning autonomy, occupational functioning, cognitive functioning, financial issues, interpersonal relationships and leisure time (min. value = 0; max. value = 72, with higher values reflecting poorer function) Rosa AR, Sánchez-Moreno J, Martínez-Aran A, Salamero M, Torrent C, Reinares M, m.fl. Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder. Clin Pract Epidemiol Ment Health CP EMH. 7. juni 2007;3:5. |
at inclusion, at follow-up around 4 months, and if in control group at around 7-8 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in automatically smarthone-generated data
Time Frame: 4-8 months
|
Automatically smartphone-generated data on physical - and social activity is generated in the Monsenso app using the phone's sensor-data. physical activity: location and physical activity (step count and movement) social activity: battery level, light level and screen mode. These automatically generated data has been shown to be informative in prior study: Faurholt-Jepsen M, Frost M, Vinberg M, Christensen EM, Bardram JE, Kessing LV. Smartphone data as objective measures of bipolar disorder symptoms. Psychiatry Res. 30. juni 2014;217(1-2):124-7. |
4-8 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Lars V Kessing, professor, Copenhagen Psychiatric Center
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- P-2021-809
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bipolar Disorder
-
ProgenaBiomeRecruitingBipolar Disorder | Bipolar I Disorder | Bipolar II Disorder | Bipolar Type I Disorder | Bipolar Disorder Mild | Bipolar Disorder Moderate | Bipolar Disorder SevereUnited States
-
Region StockholmKarolinska InstitutetRecruitingBipolar Disorder | Bipolar Depression | Bipolar I Disorder | Bipolar II Disorder | Bipolar Affective Disorder; Remission in | Bipolar Affective Disorder, Currently Depressed, ModerateSweden
-
Rush University Medical CenterThe Ryan Licht Sang Bipolar FoundationCompletedBipolar Disorder | Bipolar Depression | Bipolar I Disorder | Bipolar Disorder I | Bipolar Affective DisorderUnited States
-
University of PittsburghNational Alliance for Research on Schizophrenia and DepressionCompletedBipolar I Disorder | Bipolar II Disorder | Bipolar Disorder NOSUnited States
-
Hospital de Clinicas de Porto AlegreFederal University of Rio Grande do Sul; Hospital Moinhos de VentoActive, not recruitingBipolar Disorder | Bipolar Depression | Major Depressive Disorder | Bipolar I Disorder | Affective Disorder | Bipolar II DisorderBrazil
-
Medical University of South CarolinaMilken InstituteCompletedBipolar Disorder | Bipolar I Disorder | Bipolar II DisorderUnited States
-
Joshua RosenblatRecruitingBipolar Disorder | Bipolar Depression | Bipolar I Disorder | Bipolar II DisorderCanada
-
Mayo ClinicCompletedMajor Depressive Disorder, Bipolar I and Bipolar IIUnited States
-
Joshua RosenblatRecruitingBipolar Disorder | Bipolar Depression | Bipolar I Disorder | Bipolar II DisorderCanada
-
Myriad Genetic Laboratories, Inc.University of MinnesotaCompletedMajor Depressive Disorder, Bipolar I and Bipolar IIUnited States
Clinical Trials on psychoeducation in groups
-
University of AarhusUniversity of Rwanda; Mental Health Centre CopenhagenCompleted
-
University of AarhusGlostrup University Hospital, Copenhagen; TrygFonden, Denmark; Sygekassernes...CompletedAttention Deficit Hyperactivity DisorderDenmark
-
Virginia Polytechnic Institute and State UniversityUniversity of Virginia; Autism Speaks; National Center for Advancing Translational...CompletedAutism Spectrum DisorderUnited States
-
Karolinska University HospitalCompleted
-
University of AarhusCompleted
-
Fundacion para la Formacion e Investigacion Sanitarias...UnknownChildhood Obesity PreventionSpain
-
University Hospital of North NorwayThe Royal Norwegian Ministry of Health; Finnmark Hospital Trust; Norwegian Foundation... and other collaboratorsCompleted
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingLung Cancer Screening | Current or Past Cigarette SmokerUnited States
-
City, University of LondonThe Stroke Association, United KingdomCompleted